Klein Lawrence Otto 4
4 · CRISPR Therapeutics AG · Filed Aug 18, 2022
Insider Transaction Report
Form 4
Klein Lawrence Otto
Chief Business Officer
Transactions
- Award
Restricted Stock Units
2022-08-16+12,500→ 12,500 total→ Common Shares (12,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]The restricted stock units shall vest in full on August 16, 2023, subject to continued service to the Company or any of its subsidiaries.